Price movement over the last 24 hours
Appian Corp vs Procter & Gamble Co — how do they compare? Appian Corp trades at $25.5 (market cap $1.86B), while Procter & Gamble Co trades at $147.08 (market cap $342.40B). The key difference: Procter & Gamble Co is far larger — about 184.1× Appian Corp's market cap, and Procter & Gamble Co pays a 2.9% dividend while Appian Corp pays none. Which is the better fit depends on your goals.
| APPN | PG | |
|---|---|---|
Market Cap | $1.86B | $342.40B |
Sector | Technology | Consumer Staples |
52-Week High | $45.64 | $167.18 |
52-Week Low | $18.72 | $138.10 |
Enterprise Value | $1.95B | $367.88B |
Volume | — | 6,423,436 |
Dividend Yield | — | 2.9% |
Signals from Pluang's Aura AI — not financial advice
Appian (APPN) trades at $25.36, up 0.48% on the day, with a bullish technical signal from moving averages and a consensus price target of $26.20. The company reported positive net income in 2025 after years of losses, with revenue growing to $726.94M and operating cash flow improving to $62.87M. Recent news highlights focus on AI strategy and enterprise adoption, though the CEO's share sale and negative shareholder equity present mixed signals.
The outlook is cautiously optimistic with revenue growth and cash flow recovery, but risks include high debt levels, negative equity, and intense competition. Analyst sentiment is mixed with a majority Hold rating. The stock offers potential from AI-driven growth but requires monitoring of profitability sustainability and balance sheet health.
Procter & Gamble (PG) trades at $147.04, up 0.13% on the day, with a bearish technical signal from moving averages but neutral oscillators. The company reported consistent earnings beats in recent quarters, with Q2 2026 EPS expected at $1.42. Revenue for 2025 reached $84.28 billion, with a net income margin of 19.16%. Analysts maintain a consensus Buy rating, with a price target of $159.75, suggesting potential upside. Recent news highlights PG's dividend reliability and supply chain improvements.
PG offers a stable investment with strong fundamentals and a history of dividend growth, but faces risks from premium valuation and modest revenue growth. The stock's near-term performance may hinge on Q2 earnings and macroeconomic trends, with support at $146 providing a cushion against declines.
Trailing returns across standard periods
Latest headlines on both assets
Appian Corp provides a low-code software development platform as a service that enables organizations to rapidly develop powerful and unique applications. With its platform, organizations can rapidly and easily design, build and implement powerful, enterprise-grade custom applications through intuitive, visual interface with little or no coding required. The company's customers use applications built on its low-code platform to launch new business lines, automate vital employee workflows, manage complex trading platforms, accelerate drug development and build procurement systems. The group generates a majority of its revenue from the domestic market. It serves various industries such as education.
Read more on APPN →The Procter & Gamble Company manufactures and markets consumer products in countries throughout the world. The Company provides products in the laundry and cleaning, paper, beauty care, food and beverage, and health care segments. Procter & Gamble products are sold primarily through mass merchandisers, grocery stores, membership club stores, drug stores, and neighborhood stores.
Read more on PG →